Clinical Trial Update: First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma [Phase 1]

View source ↗

Summary

CEBIOTEX announced the completion of its first-in-man Phase 1 trial of CEB-01 PLGA Membrane for locally advanced or recurrent soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• CEB-01 PLGA Membrane (CEB-01 PLGA Membrane)

Snippet

Sponsor: CEBIOTEX | Conditions: Locally Advanced Soft Tissue Sarcoma, Recurrent Soft Tissue Sarcoma | Phase 1 | Status: COMPLETED